Effect of Sacubitril/Valsartan on Cognitive Function in Patients With Heart Failure With Preserved Ejection Fraction: A Prespecified Analysis of PARAGON-HF

  • Published on 09/02/2024
  •  Reading time: 9 min.

Dewan, Pooja Mbbs, Phd*,; Shen, Li Mbchb, Phd*,,; Pedro Ferreira, Joao Phd*,,; Jhund, Pardeep S.Mbchb, Phd; Anand, Inder S.Md, Dphil; Chandra, Alvin Md; Chiang, Lu-May Phd; Claggett, Brian Phd; Desai, Akshay S.Md, Mph; Gong, Jianjian Phd; Lam, Carolyn S.P.Mbbs, Phd; Lefkowitz, Martin P.Md; Maggioni, Aldo P.Md; Martinez, Felipe Md; Packer, Milton Md; Redfield, Margaret M.Md; Rouleau, Jean L.Md; Van Veldhuisen, Dirk J.Md; Zannad, Faiez Md; Zile, Michael R.Md; Solomon, Scott D.Md; Mcmurray, John J.V.MD

Abstract

Background A hypothetical concern has been raised that sacubitril/valsartan might cause cognitive impairment because neprilysin is one of several enzymes degrading amyloid-[beta] peptides in the brain, some of which are neurotoxic and linked to Alzheimer-type dementia. To address this, we examined the effect of sacubitril/valsartan compared with valsartan on...

ContentGeneMD

To continue reading this article in Full-Text...

* Access is totally free, without commitment or condition. Service exclusively reserved for healthcare professionals.

Peer-Reviewed Journals A-Z

Search | Advanced search

Get the latest news in Cardiology

Receive our newsletter to stay up to date with the latest news in Cardiology